InnoAlliance

Services

InnoAlliance accompanies partners through the new drug R&D, in the full life cycle of from discovery, nonclinical studies and clinical studies, to post-marketing drug monitoring.

Bioanalytical and Biomaker Testing Services

Discovery

At InnoAlliance, we understand the critical role of bioanalysis in the discovery phase of drug development. Our bioanalytical services are designed to provide comprehensive support for the identification and validation of new drug candidates. With a focus on precision and reliability, we help you uncover the pharmacokinetic (PK), pharmacodynamic (PD), and toxicokinetic (TK) profiles of novel molecules, ensuring a robust foundation for your preclinical and clinical strategies. We offer quick turnarounds with competitive pricing to meet your needs of agile development.

learn more

Non-Regulated

Our Non-GXP service carries out analytical tests with data reproducibility and data quality which is able to provide solid proofs to help formulate study plans for IND and clinical trials, and enable the planning of supportive diagnostic strategies during new drug research and development.

learn more

GCLP

Our laboratories comply with global regulatory requirements, generating lab data that are qualified for global IND/NDA filing. Our experts and professionally trained team, along with experienced QA&QC, guarantee the projects meeting highest quality standards worldwide.

learn more

Biomarker and Translational Science

InnoAlliance provides flexible and fit-for-purpose strategies to facilitate translational drug research ranging from biomarker discovery to clinical applications, improving success rate of clinical trials and enabling planning of supportive diagnostic strategies during new drug research and development.

learn more